Biotech & pharma
Drug from bananas could fight Aids, hepatitis C
24 Oct 2015
A substance found in bananas and carefully edited by scientists could lead to drugs that may fight off a wide range of deadly viruses, including AIDS, hepatitis C and influenza
A biomarker for premature death
24 Oct 2015
Intimations of immortality? Gene manipulation could retard ageing
14 Oct 2015
Researchers have identified 238 genes linked to ageing, and found that switching them off extends life in yeast cells, an advance that provides new genomic targets, which could be used to boost human lifespans
Medical breakthrough as kidney grown in lab dish
08 Oct 2015
Although the kidneys cannot perform the functions of a fully formed adult kidney, the researchers hope the achievement will someday lead to new ways to treat people suffering from kidney failure
Drugs disguised as human platelets target cancer
01 Oct 2015
New test detects all viruses that infect people, animals
30 Sep 2015
The test is so sensitive that it detects variant strains of viruses that are closely related genetically
Why some smokers have healthy lungs
30 Sep 2015
Scientists customise viruses to kill bacteria
24 Sep 2015
Expert group supports human gene modification research
11 Sep 2015
A network of researchers says genetic modification of human embryos, though controversial, is essential to understand the biology of early embryos
Making nanowires from protein and DNA
09 Sep 2015
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
